(Q34813568)

English

The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from title

Gary S. Gilkeson

7

object named as

Gary S Gilkeson

1 reference

Europe PubMed Central

4 August 2017

author name string

Hideharu Sekine

1

1 reference

Europe PubMed Central

4 August 2017

Ting Ting Hsieh Kinser

2

1 reference

Europe PubMed Central

4 August 2017

Fei Qiao

3

1 reference

Europe PubMed Central

4 August 2017

Efrain Martinez

4

1 reference

Europe PubMed Central

4 August 2017

Emily Paulling

5

1 reference

Europe PubMed Central

4 August 2017

Phillip Ruiz

6

1 reference

Europe PubMed Central

4 August 2017

Stephen Tomlinson

8

1 reference

Europe PubMed Central

4 August 2017

publication date

1 April 2011

1 reference

Europe PubMed Central

4 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

4 August 2017

63

1 reference

Europe PubMed Central

4 August 2017

4

1 reference

Europe PubMed Central

4 August 2017

1076-1085

1 reference

Europe PubMed Central

4 August 2017

The complement system in systemic autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Complement in lupus nephritis: the good, the bad, and the unknown

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Interferon-alpha in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

The candidate gene approach: have murine models informed the study of human SLE?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

The role of complement in the development of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Complement receptor 2 and autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Complement. First of two parts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Systemic lupus erythematosus, complement deficiency, and apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Nephritogenic autoantibodies in lupus: current concepts and continuing controversies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Hereditary deficiency of C3 in animals and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

8 July 2018

C1q deficiency and autoimmunity: the effects of genetic background on disease expression.

1 reference

https://api.crossref.org/works/10.1002%2FART.30222

21 January 2018

Effects of complement factor D deficiency on the renal disease of MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1002%2FART.30222

21 January 2018

Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.30222

21 January 2018

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

1 reference

https://api.crossref.org/works/10.1002%2FART.30222

21 January 2018

Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079315

26 October 2018

Type I IFN protects against murine lupus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the alternative complement pathway in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine models of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polyreactive autoantibodies are nephritogenic in murine lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of the B cell response to T-dependent antigens by classical pathway complement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement C4 is protective for lupus disease independent of C3

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21452327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.30222

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34813568&oldid=1562477107"